Forge Therapeutics, Evotec launch platform to discover metalloenzyme inhibitors

Less than a year after forming a strategic alliance to develop novel antibiotics against some drug-resistant superbugs, Forge Therapeutics and Evotec have expanded ...

Forge Therapeutics, Evotec launch platform to discover metalloenzyme inhibitors2017-10-19T14:53:58-07:00
Go to Top